Scientific data from clinical trials: investigators' responsibilities and rights.

MUC4 expression increases progressively in pancreatic intraepithelial neoplasia.

Scientific data from clinical trials: investigators' responsibilities and rights.

Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations.

Discovery of novel tumor markers of pancreatic cancer using global gene expression technology.

Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.

Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway.

Diagnostic laparoscopy for periampullary and pancreatic cancer: what is the true benefit?

Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation.

Almost all infiltrating colloid carcinomas of the pancreas and periampullary region arise from in situ papillary neoplasms: a study of 39 cases.